Learn more

METHYLGENE INC

Overview
  • Total Patents
    378
  • GoodIP Patent Rank
    156,252
About

METHYLGENE INC has a total of 378 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are PHENEX FXR GMBH, SHINOGI CO and ACOUSIA THERAPEUTICS GMBH.

Patent filings per year

Chart showing METHYLGENE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Vaisburg Arkadii 175
#2 Raeppel Stephane 113
#3 Deziel Robert 92
#4 Zhan Lijie 89
#5 Gaudette Frederic 86
#6 Claridge Stephen William 83
#7 Raeppel Franck 77
#8 Leit Silvana 75
#9 Mannion Michael 71
#10 Besterman Jeffrey M 68

Latest patents

Publication Filing date Title
AU2015242996A1 Inhibitors of histone deacetylase
US2015203517A1 Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
WO2015006875A1 Process for the preparation of substituted pyrimidines
WO2014138989A1 Method and intermediates for the synthesis of hydroxamic acid compounds
AU2013205135A1 Inhibitors of histone deacetylase
US2014081017A1 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents
US2014024608A1 Inhibitors of histone deacetylase and prodrugs thereof
WO2013044360A1 Inhibitors of protein tyrosine kinase activity
WO2013044362A1 Selected inhibitors of protein tyrosine kinase activity
US2013096136A1 Inhibitors of Protein Tyrosine Kinase Activity
WO2013044361A1 Inhibitors of protein tyrosine kinase activity
AU2012201671A1 Histone deacetylase inhibitors for enhancing activity of antifungal agents
BR112013003889A2 methods for inhibiting the development of a fungus or fungal unit thereof, for treating and / or preventing fungal infection and / or keratinized tissue disease, for sensitizing a fungus or fungal uinity thereof, and for enhancing the activity of a antifungal agent kit and composition
AU2011291398A1 Antifungal agents and uses thereof
AU2011241420B2 Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders
WO2009100536A1 Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures
CA2703718A1 Inhibitors of histone deacetylase
CN101861151A Cancer combination therapy with a selective inhibitor of histone deacetylase HDAC1, HDAC2 and/or HDAC3 and a microtubule stabilizer
EP2426108A1 Processes and intermediates for preparing fused heterocyclic kinase inhibitors
TW200916447A Sirtuin inhibitors